{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:55:10Z","timestamp":1760982910137},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"834","license":[{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The prognosis of patients with metastatic adrenal cortical carcinoma is poor, and their disabling symptoms are usually unresponsive to conventional therapy. A patient with Cushing\u2019s syndrome secondary to a secretory adrenal cortical carcinoma was treated with octreotide, endocrine therapy and chemotherapy having failed. Treatment led to a dramatic relief of her symptoms with a fall in corticosteroid secretion. Somatostatin analogue therapy for this tumour should be encouraged in view of the lack of alternative palliative treatment.<\/jats:p>","DOI":"10.1136\/pgmj.71.834.229","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:25:21Z","timestamp":1230585921000},"page":"229-230","source":"Crossref","is-referenced-by-count":5,"title":["Secretory symptoms from metastatic adrenal cortical carcinoma responding to octreotide"],"prefix":"10.1093","volume":"71","author":[{"given":"H S","family":"Pandha","sequence":"first","affiliation":[{"name":"Department of Clinical Oncology, Hammersmith Hospital , Du Cane Road, London W12 ONN , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Harrington","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Hammersmith Hospital , Du Cane Road, London W12 ONN , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Saini","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Hammersmith Hospital , Du Cane Road, London W12 ONN , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Lynn","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Hammersmith Hospital , Du Cane Road, London W12 ONN , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Hammersmith Hospital , Du Cane Road, London W12 ONN , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Waxman","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Hammersmith Hospital , Du Cane Road, London W12 ONN , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1995,4,1]]},"reference":[{"key":"ref_1","first-page":"972","article-title":"Adrenocortical carcinoma in surgically treated patients: a retrospective study by the French Association of Endocrine Surgery","volume":"112","author":"Icard, P.; Chapuis, Y.; Andresian, B.; Bernard, A.; Proy, C.","year":"1992","unstructured":"Icard P, Chapuis Y, Andresian B, Bernard A, Proy C. Adrenocortical carcinoma in surgically treated patients: a retrospective study by the French Association of Endocrine Surgery. Surgery 1992; 112: 972-9.","journal-title":"Surgery"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0140-6736(92)91700-I","article-title":"Control of emesis in bowel obstruction in terminally ill patients","volume":"339","author":"Khoo, D.; Riley, J.; Waxman, J.","year":"1992","unstructured":"Khoo D, Riley J, Waxman J. Control of emesis in bowel obstruction in terminally ill patients. Lancet 1992; 339: 375-6.","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/bmj.300.6735.1313-a","article-title":"Somatostatin analogue treatment for malignant hypercalcaemia","volume":"300","author":"Harrison, M.; James, N.; Broadley, K.","year":"1990","unstructured":"Harrison M, James N, Broadley K, et al. Somatostatin analogue treatment for malignant hypercalcaemia. BMJ 1990; 300: 1313-4.","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2265.1990.tb00867.x","article-title":"Treatment of Cushing's syndrome with somatostatin analogue SMS 201-99.5 (Sandostatin)","volume":"32","author":"Invitti, C.; De Martin, M.; Bunam, M.; Cavagini, F.","year":"1990","unstructured":"Invitti C, De Martin M, Bunam M, Cavagini F. Treatment of Cushing's syndrome with somatostatin analogue SMS 201-99.5 (Sandostatin). Clin Endocrinol 1990; 32: 275-81.","journal-title":"Clin Endocrinol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1651-2227.1981.tb06246.x","article-title":"Effect of somatostatin infusion on intermediate metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia","volume":"70","author":"Aynsley-Green, A.; Barnes, N.D.; Adrian, T.E.; Kingston, J.; Bloom, SR","year":"1981","unstructured":"Aynsley-Green A, Barnes ND, Adrian TE, Kingston J, Bloom SR. Effect of somatostatin infusion on intermediate metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia. Acta Paediatr Scand 1981; 70: 889-95.","journal-title":"Acta Paediatr Scand"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1530\/acta.0.1200760","article-title":"The effect of long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease","volume":"120","author":"Lamberts, S.W.J.; Uitterlinden, P.; Kliijn, S.M.G.","year":"1989","unstructured":"Lamberts SWJ, Uitterlinden P, Kliijn SMG. The effect of long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease. Acta Endocrinol 1989; 120: 760-6.","journal-title":"Acta Endocrinol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/71\/834\/229\/50218810\/postgradmedj-71-229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/71\/834\/229\/50218810\/postgradmedj-71-229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T23:06:00Z","timestamp":1683759960000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/71\/834\/229\/7044167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4,1]]},"references-count":6,"journal-issue":{"issue":"834","published-online":{"date-parts":[[1995,4,1]]},"published-print":{"date-parts":[[1995,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.71.834.229","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1995,4]]},"published":{"date-parts":[[1995,4,1]]}}}